Lantheus Holdings (LNTH) Non-Current Debt (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Non-Current Debt came in at $569.6 million in Q1 2026, up 0.62% year-on-year from $566.1 million in Q1 2025, and little changed on a QoQ basis from $568.7 million in Q4 2025.

Lantheus Holdings (LNTH) Non-Current Debt (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Non-Current Debt data on file, last reported at $569.6 million in Q1 2026.

  • On a quarterly basis, Non-Current Debt rose 0.62% year-over-year to $569.6 million in Q1 2026; TTM through Mar 2026 was $569.6 million, a 0.62% increase from a year earlier, with the FY2025 full-year figure at $568.7 million, up 0.6% from the prior year.
  • Non-Current Debt for Q1 2026 stood at $569.6 million, roughly flat from $568.7 million in the prior quarter.
  • Over the last five years, Non-Current Debt for LNTH reached as high as $569.6 million in Q1 2026 and fell as low as $613000.0 in Q3 2024.
  • Historically, Non-Current Debt has averaged $458.6 million across 5 years, with a median of $561.7 million in 2023.
  • Across the five-year window, Non-Current Debt sank 99.89% in 2024 and soared 92548.78% in 2025, its largest moves.
  • Year by year, Non-Current Debt stood at $557.7 million in 2022, then climbed by 0.71% to $561.7 million in 2023, then increased by 0.64% to $565.3 million in 2024, then grew by 0.6% to $568.7 million in 2025, then grew by 0.16% to $569.6 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Debt figures were $569.6 million in Q1 2026, $568.7 million in Q4 2025, and $567.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 10.34 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 14.02 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 9.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 27.86 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 12.41 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.74 Bn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn 569.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 569.60 Mn
Dec 31, 2025 568.68 Mn
Sep 30, 2025 567.94 Mn
Jun 30, 2025 566.85 Mn
Mar 31, 2025 566.10 Mn
Dec 31, 2024 565.28 Mn
Sep 30, 2024 613,000.00
Jun 30, 2024 563.19 Mn
Mar 31, 2024 562.47 Mn
Dec 31, 2023 561.67 Mn
Sep 30, 2023 560.58 Mn
Jun 30, 2023 559.24 Mn
Mar 31, 2023 558.54 Mn
Dec 31, 2022 557.71 Mn
Sep 30, 2022 152.06 Mn
Jun 30, 2022 155.66 Mn
Mar 31, 2022 159.37 Mn
Dec 31, 2021 163.12 Mn
Sep 30, 2021 166.74 Mn
Jun 30, 2021 169.25 Mn